MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Clinical differentiation between dystonic tremor and Parkinson’s disease based on tremor characteristics

    T. Tsuboi, K. Sawada, S. Hoshino, M. Higuchi, M. Muto, Y. Ito, M. Hashida, T. Ishizaki, S. Kato, D. Nakatsubo, T. Tsugawa, S. Maesawa, M. Sato, K. Hiraga, T. Uematsu, D. Tamakoshi, D. Fukushima, M. Suzuki, R. Saito, M. Katsuno (Nagoya, Japan)

    Objective: We aimed to identify clinical characteristics that are useful for differentiating dystonic tremor (DT) and Parkinson's disease (PD). Background: DT is often challenging to…
  • 2024 International Congress

    Genome-Wide Association Study revealing novel risk loci associated with Age at Onset of Parkinson’s Disease

    YS. Hwang, SY. Jo, SH. Lee, KY. Park, SJ. Chung (Jeonju, Republic of Korea)

    Objective: This study aimed to determine single-nucleotide polymorphisms (SNPs) associated with AAO in Korean PD patients. Background: Age at onset (AAO) of Parkinson’s disease (PD)…
  • 2024 International Congress

    Utility of using long-read whole genome sequencing to solve exome negative early-onset and familial Parkinson’s disease: a series of 106 individuals

    G. Cogan, K. Bilingsley, K. Daida, C. Tesson, T. Courtin, M. Ferrien, A. Singleton, S. Lesage, C. Blauwendraat, A. Brice (Paris, France)

    Objective: (i) To identify complex variants usually not visible by short-read whole exome sequencing in known genes of Parkinson’s disease (PD) such as structural variants…
  • 2024 International Congress

    Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities

    J. Kim, I. Foote, S. Bandres-Ciga, 23. Research Team, C. Marshall, A. Grotzinger3, A. Singleton, A. Brentnall, C. Blauwendraat, A. Noyce, G. Genetics Program (London, United Kingdom)

    Objective: To comprehensively investigate the genetic relationship between Parkinson’s disease (PD), its risk factors, and comorbidities by constructing a factor model of the shared genetic…
  • 2024 International Congress

    A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

    R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

    Objective: (i) To describe the demographic, clinical and genetic features of a large cohort of familial autosomal dominant Parkinson’s disease (PD) patients in the UK.(ii)…
  • 2024 International Congress

    Real-Time Removal of Stimulus Artifact for Closed-Loop Deep Brain Stimulation by Synchronized Sample-And-Hold Artifact Blanking (SSAB): Verification in Animal Model

    YH. Wu, HC. Lin, CW. Huang, CC. Hsieh, MD. Ker (Hsinchu City, Taiwan)

    Objective: To develop and validate a real-time stimulus artifact removal analog front-end (AFE) by synchronized sample-and-hold artifact blanking (SSAB) technique with the Parkinsonian minipig model…
  • 2024 International Congress

    Linear Mixed-Effect Modelling of Antisaccades in Parkinson’s Disease and Progressive Supranuclear Palsy

    S. Patel, O. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: This study aims to investigate variations in antisaccade parameters (latency, damping ratio, peak velocity, and amplitude) among different stages of Parkinson's Disease (PD), Progressive…
  • 2024 International Congress

    IPSC-derived Cortical Neurons from Parkinson’s Patients with VPS35 Mutation show Defects in Synapto- and Neurogenesis

    U. Scheller, CK. Lee, P. Seibler, M. Mitkovski, JS. Rhee, C. van Riesen (Goettingen, Germany)

    Objective: Investigate whether the Parkinson’s disease (PD) VPS35 D620N mutation leads to synaptic dysfunction in human cortical iPSC-derived neurons. Background: Early presynaptic dysfunction and cortico-striatal…
  • 2024 International Congress

    Enviromental Risk Factors for Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network

    N. Obianozie, O. Ojo, 0. Agabi, N. Okubadejo, N. Research Network (Abuja, Nigeria)

    Objective: To determine the risk factors associated with Parkinson’s disease (PD) development in the Nigerian PD Research (NPDR) cohort Background: PD is widely believed to…
  • 2024 International Congress

    Effect of Diabetes Mellitus on the Phenotype of Parkinson’s Disease

    IH. Kwak, HI. Ma, YE. Kim, JJ. Lee (Anyang-si, Republic of Korea)

    Objective: In this study, we aim to investigate whether Type 2 diabetes (T2DM) influences the phenotype of Parkinson’s disease (PD). Background: In PD, T2DM may…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • #25179 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley